PulmoBioMed commercialises state-of-the-art exhaled breath condensate & aerosol sampling technology as part of a platform for disease and environmental diagnostics. Our lead product, PBM-HALE is a passive fluid aerosol sampler engineered to segregate exhaled and environmental particles by size. Our technology solves key pains in avoiding sample contamination, preventing sample loss and generating highly reproducible data with digital molecular precision. The first of a series of products, PBM-HALE has demonstrated utility in biological agent capture, genomic/microbiomic analytics, and metabolomic profiling, through a one-stop solution. Our vision is to develop the first hand-held biomolecular analyser for medical, veterinary, well-being and environmental use. Our mission is to deliver molecular diagnostic-grade health data from your lips to your hand. PulmoBioMed Ltd. is a Northumbria University spinout company supported by the Northern Accelerator, iCURe, and InnovateUK.
Location: United Kingdom, England, Newcastle upon Tyne
Employees: 1-10
Total raised: $1.76M
Founded date: 2020
Investors 1
| Date | Name | Website |
| 25.01.2024 | Startup Fu... | sfccapital... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.02.2024 | - | $1.76M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 08.02.2024 | PulmoBioMed Raises £1.4M in Funding | PulmoBioMed, a Newcastle Upon Tyne, UK-based breath sampling technology company, raised £1.4M in fun... | finsmes.co... |
| - | PulmoBiomed | “Pulmobiomed has developed a best-in-class exhaled breath condensate device, capable of capturing Co... | fastfounde... |